Survival outcomes of patients with tropomyosin receptor kinase fusion-positive cancer receiving larotrectinib versus standard of care: a matching-adjusted indirect comparison using real-world data - Bokemeyer, C; Abrams, K; Garcia-Foncillas, J; Italiano, A; Lassen, UN; Linsell, L; Marian, M; Paracha, N; Sullivan, S; Thompson, J (Annals Of Oncology, 2024)